Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.0025 | 0.9 |
mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.0036 | 1 |
mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0047 | 1 |
mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |